Enhancing agriculture to improve food security
Understanding the mechanisms that ensure higher agricultural productivity can help the nation develop crop strains that are resistant to biotic and abiotic stresses and/or utilize soil nutrition efficiently.
Creating human disease models and finding cures
Learning the intricacies of hematopoiesis, the formation of blood cells during embryonic development and adulthood, and the biology of stem cells will help us decipher the cellular processes underlying certain cancers and blood disorders and develop therapeutic interventions.
Mitigating the threat of antibiotic resistance
TIGS is exploring pathways to reverse antibiotic resistance in select pathogenic bacteria. The research holds promise in combating antibiotic-resistant superbugs, which are becoming an increasing concern in global healthcare.
Making vector-borne diseases a problem of the past
Research groups at TIGS are working on applying new tools and techniques in genetics for sustainable, safe, and ethical management of mosquito-borne diseases such as malaria, Zika, dengue and chikungunya.
Engineering antibodies to neutralize disease pathogens
TIGS is working on identifying antibody fragments with pathogen-blocking properties. Research at TIGS aims to engineer such fragments and study their stability, affinity, avidity and efficacy and to use them to control disease transmission.
Advocating the ethical use of new technologies
A dedicated group of researchers at TIGS studies, evaluates and addresses the ethical, social and moral concerns of new genetic technologies. Public debates and discussion forums with both regulators and the community foster a participatory approach to disseminating new technologies.